Irbesartan

Images are for illustration purposes only;
actual packaging may vary.

Irbesartan is a potent angiotensin II receptor blocker (ARB) commonly used in the management of hypertension and nephropathy in patients with type 2 diabetes. By selectively inhibiting the binding of angiotensin II to the AT1 receptor, irbesartan effectively reduces vasoconstriction and aldosterone secretion, leading to decreased blood pressure and improved cardiovascular outcomes.

Its pharmacological action helps in protecting renal function, making it a valuable option for patients with diabetic nephropathy. Irbesartan is well-tolerated, with a favorable side effect profile, and is often considered in patients who require an alternative to ACE inhibitors due to cough or angioedema. Its use in compounded formulations allows for tailored dosing and combination therapies, enhancing patient adherence and therapeutic efficacy.

Trusted by 60,357 patients to date.

A group of faces of our past satisfied patients.

Custom made in our compounding labs.

Personalized treatment for better results.

All strengths and ingredients are tailored to your needs.

This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.

This is some text inside of a div block.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

Item 1
Item 2
Item 3

Unordered list

Item A
Item B
Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Active Ingredient Information

Irbesartan is a potent angiotensin II receptor blocker (ARB) commonly used in the management of hypertension and nephropathy in patients with type 2 diabetes. By selectively blocking the binding of angiotensin II to the AT1 receptor, irbesartan effectively reduces vasoconstriction, aldosterone secretion, and sodium reabsorption, leading to decreased blood pressure and improved cardiovascular outcomes.

Its pharmacokinetic profile is characterized by high oral bioavailability and a long half-life, allowing for once-daily dosing, which enhances patient compliance. Irbesartan is metabolized primarily by the liver, with minimal renal excretion, making it a suitable option for patients with varying degrees of renal impairment.

In clinical practice, irbesartan is often preferred for its favorable side effect profile, which includes a lower incidence of cough and angioedema compared to ACE inhibitors. It is also associated with protective renal effects, particularly in diabetic patients, by reducing proteinuria and slowing the progression of kidney disease.

When considering irbesartan for treatment, it is important to monitor blood pressure regularly and adjust the dosage as needed to achieve optimal therapeutic outcomes. Additionally, irbesartan can be used in combination with other antihypertensive agents to achieve better blood pressure control in patients with resistant hypertension.

Formulas using

Irbesartan

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.